4th Nordic Platelet Symposium
Reykjavik 28. – 29. March 2025

Day 1: March 28, 2025

9:30 – 11:30
Immune Thrombocytopenia
(Chairs: Waleed Ghanima and John Semple)

1. The Pathophysiology of ITP – what have we learned since the 3rd platelet symposium? (Sylvain Audia, Dijon, France)
2. The role of molecular biology in predicting response to treatment of ITP? (Tomas Jose Gonzales-Lopez, Dept. of Haematology, Burgos Spain)
3. Real World Evidence exploring the potentials of existing agents (Guillaume Moulis, Toulouse, France)
4. ITP: New targets, new agents, and new possibilities (Galina Tsykunova, Oslo University Hospital, Norway)
5. The Potential Role of Artificial Intelligence in Advancing Immune Thrombocytopenia Research (Drew Provan, Centre for Immunology, London UK and Waleed Ghanima, Oslo University Hospital Norway)

 

11:30 – 11:45
Coffee Break

 

11:45 – 13:15
Platelet Clinical Lab
(Chair: Marie-Therese Ahlen)

1. Assessment of platelet phenotypes by immunofluorescence microscopy on peripheral blood smears (Carlo Zaninetti, Institute for Transfusion Medicine, Greifswald University Hospital, Germany)
2. Platelet Function Studies (Timea Szanto, Helsinki University Hospital, Finland)
3. The APAC Antiplatelet-Anticoagulant Story (Riitta Lassilla, Helsinki University Hospital, Finland)

 

13:15 – 14:00
Lunch Break

 

14:00 – 15:30
Whole Genome Sequencing in Platelet Disorders
(Chairs: Mimi Kjaersgaard and Eva Leinøe)

1. WGS and inherited thrombocytopenia – new kids in the block (Eva Leinøe, Dept. Haematology and Genomic Medicine, Rigshospitalet, Copenhagen, Denmark)
2. An evidence-based framework to evaluate the Clinical Validity of Gene-Disease Associations (Andreas Ørslev Rasmussen, Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark)
3. Outcome of WGS in ITP – pilot study (Eva Zetterberg, Coagulation Unit, Skaane University Hospital, Malmö, Sweden)

 

15:30 – 15:45
Coffee Break

 

15:45 – 16:30
Nordic Platelet Symposium Keynote Lecture
Hemostasis without clot formation – how platelets guard the vasculature in inflammation, infection, and malignancy (Steffen Massberg, Munich University Hospital, Germany)

16.30 – 17:15
Abstract Presentations

 

19:30
Dinner

Day 2: March 29, 2025

9:00 – 9.40                                                                                                                                                         Thrombotic Thrombocytopenic Purpura                                                                                                  (Chair: Ólafur Eysteinn Sigurjónsson)

1. Update on TTP treatment (Marie Scully, University College London Hospitals UK)

 

9:40 – 11.10
Platelets in Other Diseases
(Chairs: Riitta Lassila and John Semple)

1. The association between BDNF, platelet dysfunction, and cognitive impairment (Marie Lordkipanidze, Research Center, Montreal Heart Institute, Montreal, Quebec, Canada)
2. EV and serum markers and VTE population-based studies (Omri Snir, Tromsø, Norway)
3. Platelet Factor 4 associated syndromes (Hanna Pitkänen, Helsinki University Hospital, Finland)

 

11:10 – 11:30
Coffee Break

 

11.30 -13.00                                                                                                                                                          Platelets and Complement disease                                                                                                                (Chair: Eva Zetterberg)

1. The complement and contact systems in thrombotic kidney disease (Diana Karpman, Department of Paediatrics, Skane University Hospital, Lund, Sweden)

 

2. The paradigm of complement inhibition in PNH (Alexandros Arvanitakis, Dept. of Hematology, Skane University Hospital, Malmoe, Sweden)

 

3. Interactions between platelets and complement (Per Nilsson Institution of Chemistry and Biomedicine, Linné University, Sweden)

 

4. 00 – 14.00
   Lunch Break